Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT06866548 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06866548
- Sponsor
- Shanghai Changzheng Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-10
- Primary completion
- 2025-11-11
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.